BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Accenture
US Army
Healthtrust
Julphar
Express Scripts
McKinsey
QuintilesIMS
Deloitte
Fish and Richardson

Generated: January 18, 2018

DrugPatentWatch Database Preview

LONITEN Drug Profile

« Back to Dashboard

Which patents cover Loniten, and when can generic versions of Loniten launch?

Loniten is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in LONITEN is minoxidil. There are eight drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
Drug patent expirations by year for LONITEN
Medical Subject Heading (MeSH) Categories for LONITEN

US Patents and Regulatory Information for LONITEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn LONITEN minoxidil TABLET;ORAL 018154-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn LONITEN minoxidil TABLET;ORAL 018154-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LONITEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn LONITEN minoxidil TABLET;ORAL 018154-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn LONITEN minoxidil TABLET;ORAL 018154-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Healthtrust
Boehringer Ingelheim
Fuji
McKinsey
McKesson
Dow
Deloitte
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot